January 2026 Consumer Search Analysis Examines How Shoppers Evaluate Single-Ingredient vs Multi-Ingredient Berberine ...
A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...
Amazon’s acquisition of Bee highlights a shift in how the company views AI assistants. Rather than focusing only on smart ...
The authors of the study, published in Cell Reports Medicine, are optimistic that it could pave the way for potential ...
POWELL, OH - January 08, 2026 - PRESSADVANTAGE - Be Aligned Health, a chiropractic office based in Powell, Ohio, ...
7d
Chiropractor Evansville Shares Perspective on the Role and Structure of Modern Chiropractic Services
January 10, 2026 - PRESSADVANTAGE - Chiropractor Evansville has released an announcement outlining its approach to ...
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of ...
YARTEMLEA is the first and only approved lectin pathway inhibitor. YARTEMLEA selectively inhibits MASP-2, the effector enzyme of the lectin pathway, blocking pathway activation while preserving ...
Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...
A central theme of this series has undoubtedly been how humans and AI systems can − or should − interact in a harmonious, symbiotic way. And award-winning author and neuro-ophthalmologist, Mithu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback